MAPT and Alzheimer disease: Because the increase in Aβ precedes the increase in tau measured on PET and the decline in cognitive function during the evolution of AD,26 it is possible that the PBO cohort that we studied was relatively young to show effects of PBO on tau deposition, particularly in the early PBO group (median age at assessment of 64.8 years).27